Brussels, 19.11.2024

COM(2024) 529 final

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

on export authorisations in 2023 pursuant to the Regulation concerning trade in certain




goods which could be used for capital punishment, torture or other cruel, inhuman or




degrading treatment or punishment


1.Introduction

The objective of Regulation (EU) 2019/125 concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment 1  (‘the Regulation’) is to prevent, in countries outside the EU, capital punishment, on the one hand, and torture and other cruel, inhuman or degrading treatment or punishment, on the other. It distinguishes between:

-goods that are inherently abusive and should not be traded at all (Annex II); and

-goods that can have legitimate uses, such as law enforcement equipment (Annex III) and goods for therapeutic use (Annex IV).

Trade in goods listed in Annex III and IV is subject to certain restrictions.

Article 26(3) of the Regulation states that the Member States must draw up a public, annual activity report. The report must provide information on the number of applications received, the goods and countries concerned, and the decisions taken on the applications. Article 26(4) states that the Commission must draw up an annual report comprised of the annual activity reports published by the Member States. It must make the report publicly available.

This Commission report provides information on Member States’ authorisation activities concerning exports of goods in 2023 2  that could be used for torture or for capital punishment.

All Member States have reported on the number of export authorisations granted and refused under Articles 11(1) and 16(1) of the Regulation and on the goods and countries of destination in question. In some cases, the competent authorities in the Member States have also reported on the numbers or quantities of goods authorised for export and the category of end-user to whom the goods were supplied.

Authorisations under Regulation (EU) 2019/125

Articles 11(1) and 16(1) of the Regulation require an authorisation for exports 3 of goods listed in Annex III and Annex IV respectively.

Annex III lists certain goods that could be used for torture or other cruel, inhuman or degrading treatment or punishment. Goods in Annex III fall under the following headings: goods designed for restraining human beings; weapons and devices designed for the purpose of riot control or self-protection; and weapons and equipment disseminating incapacitating or irritating chemical substances for the purpose of riot control or self-protection, and certain related substances.

Annex IV lists certain chemicals that could be used in lethal injections.

Except where the Union general export authorisation (GEA) set out in Annex V is used for exports of goods listed in Annex IV, the authorisation to export has to be obtained from the competent authorities of the Member State concerned, as listed in Annex I to the Regulation.

Exports to destinations listed in the Union GEA can usually take place without obtaining an individual or global authorisation granted by a Member State. The approach so far has been to include a non-EU country in Annex V if it has ratified a relevant international agreement with a commitment to abolish the death penalty for all crimes. For countries that are not members of the Council of Europe, that means the country in question must have ratified the Second Optional Protocol to the International Covenant on Civil and Political Rights (ICCPR) without reservation.

However, if there is reasonable suspicion about the exporter’s ability to comply with the terms of the authorisation or with export control legislation, the competent authority may prohibit the exporter from using the Union GEA.

Article 20(2) of Regulation (EU) No 2019/125 states that an export authorisation granted by a Member State can be an individual authorisation (an authorisation for exports to one end-user or consignee in a non-EU country) or a global authorisation (an authorisation for exports to one or more specified end-users or distributors in one or more specified non-EU countries) 4 .

Articles 3, 4 and 5 of the Regulation prohibit the export, import and transit, respectively, of the goods listed in Annex II. Competent authorities may grant a derogation from the prohibition, but only if it is demonstrated that the goods concerned will be used exclusively for public display in a museum (either in a non-EU country or, in accordance with Article 4, in a Member State) given their historical significance.

2.Authorisations granted and refused

In 2023, the total number of reported authorisations amounted to 214, with 11 Member States reporting that they had granted authorisations. The remaining Member States informed the Commission that they had not received any applications for authorisations pursuant to the Regulation suggesting limited activity in this field. As in the previous reporting exercises, the data does not provide a critical mass from which to draw substantiated conclusions.

As the definitions of ‘individual authorisation’ and ‘global authorisation’ in Article 2 of the Regulation do not include a quantitative component, an indication of the number of authorisations granted does not give an indication of the number or quantity of goods concerned by these authorisations. Nor does the information that Member States provide to the Commission typically distinguish between individual authorisations and global authorisations.

Member States reported that they had denied 6 applications for an export authorisation in 2023. The reported cases of denial concerned goods described in Annex III code 3.1 5  intended for export to Aruba, Chile and Egypt while goods described in Annex III code 3.4 6 were intended for export to Egypt and the Russian Federation. 

Articles 3, 4 and 5 of the Regulation prohibit the export, import, and transit, respectively, of the goods listed in Annex II. The Regulation allows the competent national authorities to grant a derogation from the prohibition, but only if it is demonstrated that the goods concerned will be used exclusively for public display in a museum (either in a non-EU country or, in accordance with Article 4, in a Member State) in view of their historical significance. The competent authorities reported that they had not granted such derogations in 2023.

Annex 1 to this report provides an overview of the number of reported export authorisations granted and refused by Member States over the period 2017-2023.

Annex 2 to this report provides information on the number of reported export authorisations issued by Member States as regards goods listed in Annex III.

Annex 3 to this report provides information on the reported destinations of authorised and refused exports as regards goods listed in Annex III.

Annex 4 to this report summarises the information provided to the Commission on the reported end use of authorised exports as regards goods listed in Annex III.

Annex 5 to this report provides a detailed overview of authorised exports of Annex III goods in 2023.

Annex 6 to this report provides information on the number of reported export authorisations issued by Member States as regards goods listed in Annex IV.

Annex 7 to this report provides information on the reported destinations of authorised exports as regards goods listed in Annex IV (no refusal has been reported).

Annex 8 to this report summarises the information provided to the Commission on the reported end use of authorised exports as regards goods listed in Annex IV.

Annex 9 to this report provides a detailed overview of authorised exports of Annex IV goods in 2023.

(1)

OJ L 30, 31.1.2019, p. 1.

(2)

This report does not provide information on exporters’ use of the Union General Export Authorisation, pursuant to Annex V to the Regulation, for exports of goods listed in Annex IV.

(3)

Article 2(d) of the Regulation defines ‘export’ as ‘any departure of goods from the customs territory of the Union, including the departure of goods that requires a customs declaration and the departure of goods after their storage in a free zone within the meaning of Regulation (EU) No 952/2013 of the European Parliament and of the Council’.

(4)

Article 2(p) fully defines ‘individual authorisation’. Article 2(q) fully defines ‘global authorisation’.

(5)

Portable weapons and equipment for administration or dissemination of a dose of an incapacitating or irritating chemical substance.

(6)

Mixtures containing at least 0,3 % by weight of PAVA or OC and a solvent (such as ethanol, 1-propanol or hexane), which could be administered as such as incapacitating or irritating agents, in particular in aerosols and in liquid form, or used for manufacturing of incapacitating or irritating agents.


Brussels, 19.11.2024

COM(2024) 529 final

ANNEXES

to the

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

on export authorisations in 2023 pursuant to the Regulation concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment


Annex 1:

Overview: Number of reported export authorisations granted and refused by Member States over the period 2017-2023

Annex 2:

Annex III goods: Number of reported export authorisations issued by Member States in 2023

Annex 3:

Annex III goods: Reported destinations 1 of authorised and refused exports in 2023

Annex 4:

Annex III goods: Reported end-use of authorised exports to third countries in 2023

Annex 5:

Overview of reported authorised exports of Annex III goods in 2023

Code

Product Description

Destination

Member State

1.1

Shackles and gang chains (except ordinary handcuffs)

Norway, Switzerland, United Kingdom, United States of America

DE

1.2

Individual cuffs or rings fitted with a locking mechanism and having an inside circumference exceeding 165 mm

Cape Verde

PT

2.1

Stun guns

Norway

SE

3.1

Portable weapons and equipment for administration or dissemination of a dose of an incapacitating or irritating chemical substance.

Albania, Andorra, Aruba, Belarus 2 , Bonaire, Sint Eustatius and Saba, Bosnia and Herzegovina, Congo (Democratic Republic of), Costa Rica, Curacao, India, Israel, Japan, Kosovo (under UNSCR 1244), Kuwait, Lebanon, Libya, Mauritius, Mongolia, Montenegro, Namibia, North Macedonia, Norway, Pakistan, Qatar, Rwanda, Saint Martin - French part, Senegal, Serbia, South Africa, Switzerland, Tunisia, United Kingdom, United States of America

CZ, DE, FR, NL, SE, ES

3.2

Pelargonic acid vanillylamide (PAVA)

Australia, India, Indonesia, New Zealand, Norway, Pakistan, South Korea, Switzerland, United Kingdom

DE

3.3

Oleoresin capsicum (OC)

Singapore, Switzerland, Tunisia, Ukraine, United Arab Emirates, United Kingdom, United States of America

DE, NL

3.4

Mixtures containing at least 0.3 % of PAVA by weight or OC and a solvent (pepper spray)

Serbia, Singapore, Switzerland, United Kingdom

DE

Annex 6:

Annex IV goods: Number of reported export authorisations issued by Member States in 2023



Annex 7:

Annex IV goods: Reported destinations 3 of authorised and refused exports in 2023

Annex 8:

Annex IV goods: Reported end-use of authorised exports to third countries in 2023

Annex 9:

Overview of reported authorised exports of Annex IV goods in 2023

Code

Product Description

Destination

Member State

1.1

(a) Amobarbital - (CAS RN 57-43-2)

 

Armenia

PL

1.1

(c) Pentobarbital - (CAS RN 76-74-4)

Armenia

PL

1.1

(d) Pentobarbital sodium salt - (CAS 57-33-0)

Aruba, Australia, Canada, Curacao, Hong Kong, Malaysia, Saint Martin - French part, United Kingdom

NL

1.1

(e) Secobarbital - (CAS RN 76-73-3)

Armenia

PL

1.1

(g) Thiopental - (CAS RN 76-75-5)

Angola, Bosnia and Herzegovina, Mauritania

AT, PT

1.1

(h) Thiopental sodium salt (CAS RN 71-73-8), also known as thiopentone sodium

Albania, Algeria, Bangladesh, Bonaire, Sint Eustatius and Saba, Ethiopia, Gabon, Georgia, Guinea Bissau, Haiti, Indonesia, Iran, Israel, Liberia, Malawi, Mexico, Saudi Arabia, Somalia, South Sudan, Ukraine, United Kingdom, Uruguay

CZ, IT, LV, NL

1.1

Other short and intermediate acting barbiturate anaesthetic agents

Armenia

PL

1.1

Products which could be used for the execution of human beings by means of lethal injection

Argentina, Australia, Brazil, Cuba, India, Iran, Israel, Japan, Jordan, Kenya, Malaysia, Mexico, New Zealand, Norway, Peru, Saudi Arabia, South Africa, South Korea, Switzerland, Uganda, United Kingdom, Uruguay

DE

(1)

If a particular name is used in the list of destinations, it should not be construed as going beyond referring to a (customs) territory commonly known by that name.

**The designation is without prejudice to positions on status and is in line with UNSCR 1244/1999 and the ICJ Opinion on the Kosovo declaration of independence.

(2)

The export is reported as being intended for export to a Mission (Consulate or Embassy)

(3)

If a particular name is used in the list of destinations, it should not be construed as going beyond referring to a (customs) territory commonly known by that name